Walgreens Is Latest To Sue Glumetza Makers Over Price Hikes

Law360 (December 2, 2019, 5:37 PM EST) -- Walgreens and a group of other retailers on Monday launched the latest lawsuit against pharmaceutical companies Bausch Health, Assertio, Salix, Santarus and Lupin in California federal court, alleging that they participated in an egregious scheme to catapult prices for diabetes drug Glumetza up to more than $3,000 for one month's supply.

Walgreen Co., The Kroger Co., Albertsons Cos. Inc. and H-E-B LP added the suit to the growing list of antitrust cases facing the four companies that once held the rights to brand-name Glumetza since 2012, as well as generic-drug maker Lupin Pharmaceuticals Inc., which manufactured an alternative to the branded...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS